Register to receive a free U.S. Market for Urological Devices report synopsis and brochure
The stone management market in the U.S. is seeing significant growth in the holmium laser and ureteral stent segments. Aside from these segments, the stone management market consists of extracorporeal shockwave lithotripsy (ESWL) capital equipment, intracorporeal shockwave lithotripsy (ISWL) capital equipment and stone fragment retrieval devices.
Ureteral stents are hollow tubes that allow urine to be drained through a catheter from the upper part of the urinary system. This market segment is experiencing healthy growth at a CAGR of 7.5%. Meanwhile, the holmium laser segment is expected to grow at a rapid CAGR of 8.1% through 2020, making it the fastest growing segment in the stone management market. Holmium lasers are the only type of lasers used in stone management. Procedures in which they are used are referred to as laser lithotripsy procedures.
Many urologists consider high powered holmium lasers, which are defined as over 80 watts, to be a cost-effective investment. This is due to the fact that the devices can be used not only for stone treatment, but also for laser benign prostate hyperplasia (BPH) treatment. The use of holmium lasers in multiple applications and its consequent return on investments makes them very appealing, thus driving the overall stone treatment device market.
Lumenis, whose holmium laser technology is distributed by Boston Scientific, is the market leader for holmium lasers. Lumenis is the largest medical laser company in the world and it was the first company to develop a 100-watt holmium laser, as seen in its VersaPulse® PowerSuite™ system. Also a significant competitor in this market segment is Dornier MedTech America, with its H20 Holmium laser system from the Medilas product family, which is distributed by Olympus.
On the ureteral stents front, the clear market leader is Boston Scientific with their successful Percuflex™, Contour™ and Polaris™ families of products. Also prominent in this segment is Cook Medical, who offers the C-Flex®, Sof-Flex® and Universa® lines of stents. C. R. Bard is also among the leaders of this market with their popular INLAY ®and BARDEX® family of ureteral stents.
“An emerging technology is antimicrobial coated stents, which have not yet gained FDA approval but could increase demand in the future,” explains Dr. Kamran Zamanian, CEO of iData. “Driven by physician preference moving away from placing nephrostomy tubes, unit sales growth is expected to increase.”
For Further Information
More on the markets for urology can be found in this latest edition report published by iData entitled U.S. Market for Urological Devices, which covers the U.S. as a whole, as well as market segments for urinary incontinence devices, stone management devices, BPH treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, and nephrostomy devices.
The iData series on the market for urological devices also covers the U.S., India, China, Japan, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by State, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.